From Calcium-dependent currents to Multitarget Therapy: A Pharmacological Strategy for Glioblastoma
Glioblastoma (GBM) is an aggressive primary brain tumor with limited treatment options and substantial interpatient heterogeneity. Ion transport and cell-volume regulation may represent pharmacological vulnerabilities in glioma stem cells (GSCs). Here, we characterized membrane currents in patient-derived GSCs, identifying a calcium-dependent anion conductance consistent with volume-regulated anion channels (VRACs) and an inward current consistent with Na+/Ca++ exchanger exchanger (NCX) activity. Based on these findings, we investigated individual compounds and developed a multitarget cocktail comprising niflumic acid (NFA), bumetanide (BTN), and R-ketorolac (R-K) to target complementary mechanisms involved in ion homeostasis, cell-volume regulation, and cellular dynamics. The cocktail affected cell viability and mechanical properties and showed synergistic effects in U87 cells and patient-derived GSCs with similar electrophysiological profiles. Treatment did not measurably alter spontaneous activity in cultured hippocampal neurons but caused substantial HMC3 cytotoxicity. Encapsulation in transferrin-functionalized liposomes attenuated HMC3 toxicity while preserving activity against glioblastoma cells, suggesting a potential strategy to improve treatment selectivity. Further pharmacological studies identified a potential vulnerability associated with NCX activity, although its contribution to cytotoxicity remains unclear. Overall, our findings highlight electrophysiological heterogeneity in patient-derived GSCs and support further investigation of ion transport as a therapeutic target in GBM. Combining multitarget pharmacology with targeted drug delivery may help address heterogeneous treatment responses, although further studies are needed to establish the underlying mechanisms, safety, and vivo efficacy.
Authors
- Ivana Manini (ORCID: https://orcid.org/0000-0002-3319-7749)
- Tamara Ius (ORCID: https://orcid.org/0000-0003-3741-0639)
- Cesar Adolfo Sánchez Triviño (ORCID: https://orcid.org/0009-0004-0273-9068)
- Renza Spelat (ORCID: https://orcid.org/0000-0001-5794-8976)
- Alessia Norbedo
- Miran Škrap (ORCID: https://orcid.org/0000-0002-6592-6416)
- Licio Collavin (ORCID: https://orcid.org/0000-0001-6815-5381)
- Elena Rampazzo (ORCID: https://orcid.org/0000-0002-5232-757X)
- Luca Persano (ORCID: https://orcid.org/0000-0002-0050-3666)
- Vincent Torre (ORCID: https://orcid.org/0000-0001-8133-3584)
- Daniela Cesselli (ORCID: https://orcid.org/0000-0002-0562-7852)
- Loredana Casalis (ORCID: https://orcid.org/0000-0001-8924-4906)
- Anna Menini (ORCID: https://orcid.org/0000-0001-9304-0412)
- Pietro Parisse (ORCID: https://orcid.org/0000-0002-7420-2778)
- Alice Scomparin
Institutions
- University of Udine (IT)
- Scuola Internazionale Superiore di Studi Avanzati (IT)
- University of Trieste (IT)
- AREA Science Park (IT)
- Elettra-Sincrotrone Trieste S.C.p.A. (IT)
- Istituto Officina dei Materiali (IT)
- Città della Speranza Foundation (IT)
Publication Details
- Journal
- bioRxiv (Cold Spring Harbor Laboratory)
- Published
- 2026-11-17
- DOI
- https://doi.org/10.64898/2026.11.16.765581
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- preprint